Fas/APO-1, a member of the NGF/TNF receptor superfamily expressed on t
he cell-surface of normal and malignant cells, is known to induce cell
death by apoptosis. In the present study, we have investigated Fas/AP
O-1 gene defects in a human osteosarcoma cell line resistant to the ap
optosis-inducing effects of anti-Fas. cDNA cloning and sequencing reve
aled that these cells contained both 'authentic' and mutant Fas/APO-1
containing a 63 base pair in-frame deletion spanning the transmembrane
domain, designated DFas/APO-1. Direct evidence for the existence of a
soluble Fas/APO-1 protein was obtained by immunoprecipitation and Wes
tern blotting. Taken together with prior studies demonstrating a role
for Fas/APO-l and Fas ligand, respectively, in tumor target cell killi
ng by cytotoxic T-lymphocytes, production of soluble Fas/APO-1 might h
ave significant implications in malignant disease pathogenesis.